U.S. Spatial Genomics And Transcriptomics Market Will Grow Rapidly In Coming Years
U.S. Spatial Genomics And Transcriptomics Market Summary The U.S. spatial genomics and transcriptomics market size was valued at USD 97.5 million in 2023 and is projected to grow at a CAGR of 12.7% from 2024 to 2030. Market expansion is primarily driven by the increasing recognition of its potential as a cancer diagnostic tool and the development of advanced in situ sequencing technologies. Additionally, rapid innovations in genomics, including human sequencing, tissue sequencing, and single-cell sequencing, have contributed to the emergence of spatial genomic sequencing, offering detailed spatial mapping of genetic information. These technological advancements, coupled with their clinical applications, are anticipated to significantly boost market growth. The U.S. spatial genomics and transcriptomics market accounted for 38% of the global market share in 2023. The expansion is strongly influenced by several key factors, such as the rising demand for personalized medi...